Xilio Therapeutics (XLO)
(Delayed Data from NSDQ)
$1.12 USD
+0.06 (5.66%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Xilio Therapeutics (XLO) reported earnings of -$0.59 per share, missing the Zacks Consensus Estimate of -$0.30 per share. This reflects a negative earnings surprise of 96.67%. Look out for XLO's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 67.14%.
Earnings History
Price & Consensus
Zacks News for XLO
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
XLO: What are Zacks experts saying now?
Zacks Private Portfolio Services